The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency

References

1. 1.↵
   National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press. 2019. Available from: http://nap.edu/25310.
2. 2.↵
   Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). 2019. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/.
3. 3.↵
   1. Crotty K,
   2. Freedman KI,
   3. Kampman KM

   . Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder. J Addict Med 2020;14:99–112.

   OpenUrl
4. 4.↵
   Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder. treatment improvement protocol (TIP) series 63, full document. HHS publication No. (SMA) 18- 5063FULLDOC. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2018.
5. 5.↵
   1. Hauk L

   . Management of Chronic pain and opioid misuse: a position paper from the AAFP. Am Fam Physician 2017;95:458–9.

   OpenUrl
6. 6.↵
   Center for Substance Abuse Treatment. Substance abuse treatment and family therapy. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK64269/. Accessed June 2, 2020.
7. 7.↵
   1. DeFlavio JR,
   2. Rolin SA,
   3. Nordstrom BR,
   4. Kazal LA

   . Jr. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health 2015;15:3019.

   OpenUrl
8. 8.↵
   1. Hutchinson E,
   2. Catlin M,
   3. Andrilla CH,
   4. Baldwin LM,
   5. Rosenblatt RA

   . Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12:128–33.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Walley AY,
   2. Alperen JK,
   3. Cheng DM,
   4. et al

   . Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med 2008;23:1393–8.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Andrilla CHA,
    2. Coulthard C,
    3. Larson EH

    . Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med 2017;15:359–62.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Peterson LE,
    2. Morgan ZL,
    3. Eden AR

    . Early-career and graduating physicians more likely to prescribe buprenorphine. J Am Board Fam Med 2020;33:7–8.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Morris NP,
    2. Bentzley BS

    . Requiring buprenorphine waivers for psychiatry residents. Acad Psychiatry 2019;43:131–4.

    OpenUrl
13. 13.↵
    Accreditation Council of Graduate Medical Education: ACGME program requirements for graduate medical education in family medicine. Available from: https://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/120_FamilyMedicine_2019.pdf?ver=2019-06-13-073936-407. Accessed March 31, 2020.
14. 14.↵
    American Academy of Family Physicians. Recommended curriculum guidelines for family medicine residents: substance use disorders. AAFP Reprint No. 277. Available from: https://www.aafp.org/dam/AAFP/documents/medical_education_residency/program_directors/Reprint277_Substance.pdf. Accessed March 31, 2020.
15. 15.↵
    1. James JR,
    2. Gordon LM,
    3. Klein JW,
    4. Merrill JO,
    5. Tsui JI

    . Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic. Subst Abus 2019;40:11–3.

    OpenUrl
16. 16.↵
    1. Tesema L,
    2. Marshall J,
    3. Hathaway R,
    4. et al

    . Training in office-based opioid treatment with buprenorphine in US residency programs: a national survey of residency program directors. Subst Abus 2018;39:434–40.

    OpenUrl
17. 17.↵
    1. Tong S,
    2. Sabo R,
    3. Aycock R,
    4. et al

    . Assessment of addiction medicine training in family medicine residency programs: a CERA study. Fam Med 2017;49:537–43.

    OpenUrl
18. 18.↵
    1. Kunins HV,
    2. Sohler NL,
    3. Giovanniello A,
    4. Thompson D,
    5. Cunningham CO

    . A buprenorphine education and training program for primary care residents: implementation and evaluation. Subst Abus 2013;34:242–7.

    OpenUrl
19. 19.↵
    1. Tong ST,
    2. Hochheimer CJ,
    3. Peterson LE,
    4. Krist AH

    . Buprenorphine provision by early career family physicians. Ann Fam Med 2018;16:443–6.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Suzuki J,
    2. Connery HS,
    3. Ellison TV,
    4. Renner JA

    . Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict 2014;23:618–22.

    OpenUrl
21. 21.↵
    1. Burke J

    1. Tuxworth E

    . Competence based education and training: background and origins. In: Burke J, ed. Competency based education and trainig. London, UK: Routledge; 2005:18–31.